首站-论文投稿智能助手
典型文献
The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth
文献摘要:
Programmed death ligand-1(PD-L1)/PD-1 checkpoint extensively serves as a central mediator of immunosuppression.A tumor-promoting role for abundant PD-L1 in several cancers is revealed.However,the importance of PD-L1 and how the PD-L1 expression is controlled in breast cancer remains obscure.Here,the mechanisms of controlling PD-L1 at the transcription and protein acetylation levels in promoting breast cancer growth are presented.Overexpressed PD-L1 accelerates breast cancer growth in vitro and in vivo.RNA-seq uncovers that PD-L1 can induce some target genes affecting many cellular processes,especially cancer development.In clinical breast cancer tissues and cells,PD-L1 and HBXIP are both increased,and their expressions are positively correlated.Mechanistic exploration identifies that HBXIP stimulates the transcription of PD-L1 through co-activating ETS2.Specifically,HBXIP induces PD-L1 acetylation at K270 site through interacting with acetyltransferase p300,leading to the stability of PD-L1 protein.Functionally,depletion of HBXIP attenuates PD-L1-accelerated breast tumor growth.Aspirin alleviates breast cancer via targeting PD-L1 and HBXIP.Collectively,the findings display new light into the mechanisms of controlling tumor PD-L1 and broaden the utility for PD-L1 as a target in breast cancer therapy.
文献关键词:
作者姓名:
Fei-fei Xu;Hui-min Sun;Run-ping Fang;Lu Zhang;Hui Shi;Xue Wang;Xue-li Fu;Xian-meng Li;Xu-he Shi;Yue Wu;Kai Ye;Wei-ying Zhang;Li-hong Ye
作者机构:
State Key Laboratory of Medicinal Chemical Biology,Tianjin Key Laboratory of Protein Sciences,Department of Biochemistry,College of Life Sciences,Nankai University,Tianjin 300071,China
引用格式:
[1]Fei-fei Xu;Hui-min Sun;Run-ping Fang;Lu Zhang;Hui Shi;Xue Wang;Xue-li Fu;Xian-meng Li;Xu-he Shi;Yue Wu;Kai Ye;Wei-ying Zhang;Li-hong Ye-.The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth)[J].中国药理学报(英文版),2022(02):429-445
A类:
HBXIP,Overexpressed,ETS2
B类:
modulation,L1,induced,by,oncogenic,breast,growth,Programmed,death,ligand,checkpoint,extensively,serves,central,mediator,immunosuppression,tumor,promoting,role,abundant,several,cancers,revealed,However,importance,how,controlled,remains,obscure,Here,mechanisms,controlling,transcription,protein,acetylation,levels,are,presented,accelerates,vitro,vivo,seq,uncovers,that,some,genes,affecting,many,cellular,processes,especially,development,In,clinical,tissues,cells,both,increased,their,expressions,positively,correlated,Mechanistic,exploration,identifies,stimulates,through,activating,Specifically,induces,K270,site,interacting,acetyltransferase,p300,leading,stability,Functionally,depletion,attenuates,accelerated,Aspirin,alleviates,targeting,Collectively,findings,display,new,light,into,broaden,utility,therapy
AB值:
0.527485
相似文献
Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/ BRAF/TAK1/ERK/ETV4 signaling
Panpan Ma;Xinxin Jin;Zhiwei Fan;Zhou Wang;Suhui Yue;Changyue Wu;Shiyin Chen;Yuanyuan Wu;Miaomiao Chen;Donghua Gu;Siliang Zhang;Renfang Mao;Yihui Fan-Laboratory of Medical Science,School of Medicine,Nantong University,Nantong 226001,China;Department of Pathogenic Biology,School of Medicine,Nantong University,Nantong 226001,China;Department of Clinical Laboratory,Yancheng No.1 People's Hospital,Yancheng 224005,China;School of Life Sciences,Nantong University,Nantong 226001,China;Department of Dermatology,Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Urology,the Second Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Radiotherapy Oncology,Harbin Medical University Cancer Hospital,Harbin 150086,China;Department of Pathophysiology,School of Medicine,Nantong University,Nantong 226001,China
ZNF3 regulates proliferation,migration and invasion through MMP1 and TWIST in colorectal cancer
Le Du;Ning Liu;Jianfeng Jin;Meng Cao;Yuantian Sun;Xinzheng Gao;Banzhan Ruan;Shangfeng Yang;Dongsheng Ge;Yingzhuan Ye;Yinxi Zhou;Erfei Chen;Jin Yang-Hainan Provincial Key Laboratory of Carcinogenesis and Intervention;Department of Biology,Hainan Medical University,Haikou 571199,China;Department of Gastrointestinal Surgery,Hainan General Hospital,Hainan Affiliated Hospital of Hainan Medical University,Haikou 571199,China;Department of Biochemistry and Molecular Biology,Hainan Medical University,Haikou 571199,China;College of Biomedical Information and Engineering,Hainan Medical University,Haikou 571199,China;Key Laboratory of Resources Biology and Biotechnology in Western China,Ministry of Education,College of Life Sciences,Northwest University,Xi'an 710069,China
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
Chengliang Sun;Yao Cheng;Xiaojia Liu;Gefei Wang;Wenjian Min;Xiao Wang;Kai Yuan;Yi Hou;Jiaxing Li;Haolin Zhang;Haojie Dong;Liping Wang;Chenguang Lou;Yanze Sun;Xinmiao Yu;Hongbin Deng;Yibei Xiao;Peng Yang-State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization,China Pharmaceutical University,Nanjing 210009,China;Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Department of Pharmacology,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Beijing Institute of Clinical Pharmacy,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China;Department of Physics,Chemistry and Pharmacy,University of Southern Denmark,Campusvej 55,5230 Odense,Denmark;Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。